Back to search

Article

Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 responses

2021-08-02

Abstract excerpt

<h4>ABSTRACT</h4> Nucleoside modified mRNA combined with Acuitas Therapeutics’ lipid nanoparticles (LNP) have been shown to support robust humoral immune responses in many preclinical animal vaccine studies and later in humans with the SARS-CoV-2 vaccination. We recently showed that this platform is highly inflammatory due to the LNPs’ ionizable lipid component. The inflammatory property is key to support the dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4b539ebd-703d-566f-b777-186a43ea756b
DOI
10.1101/2021.08.01.454662
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 responsesDOI 10.1101/2021.08.01.454662
Select a neighboring publication to make it the new centre.